remnant cholesterol fasting state
Selected indexed studies
- Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys. (Lipids Health Dis, 2025) [PMID:40275392]
- Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. (Atherosclerosis, 2023) [PMID:37826864]
- Triglycerides and cardiovascular disease. (Lancet, 2014) [PMID:25131982]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. (2023) pubmed
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. (2022) pubmed
- Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys. (2025) pubmed
- Triglycerides and cardiovascular disease. (2014) pubmed
- Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments. (2023) pubmed
- Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. (2024) pubmed
- Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. (2024) pubmed
- Remnant cholesterol, preinflammatory state and chronic kidney disease: association and mediation analyses. (2024) pubmed
- The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. (2022) pubmed
- Dyslipidemia in obesity: mechanisms and potential targets. (2013) pubmed